市场调查报告书
商品编码
1434577
3D 细胞培养市场:按产品、应用和最终用户划分 - 2024-2030 年全球预测3D Cell Culture Market by Product (3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture), Application (Cancer, Drug Discovery, Stem Cell Research), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年3D细胞培养市场规模为16.2亿美元,预计2024年将达17.3亿美元,2030年将达26.7亿美元,复合年增长率为7.34%。
3D 细胞培养的全球市场
主要市场统计 | |
---|---|
基准年[2023] | 16.2亿美元 |
预测年份 [2024] | 17.3亿美元 |
预测年份 [2030] | 26.7亿美元 |
复合年增长率(%) | 7.34% |
3D细胞培养是指在允许生物细胞在3D上扩展的环境中培养生物细胞。此方法不同于传统的二维方法,在传统的二维方法中,细胞在培养皿等平坦表面上培养。在 3D 细胞培养中,细胞比 2D 方案更接近模仿人体细胞的行为,因此可以更准确地解释体内条件。 3D 细胞培养正在帮助生物医学研究的重要领域进行研究,包括组织再生、癌症生物学和药物发现。近年来,器官移植的需求急剧增加,增加了对可以创建用于移植的仿生组织模型的3D培养的需求。然而,3D 细胞培养的开发需要复杂的基础设施,并且可扩充性有限,阻碍了其采用。微加工和生物列印技术的进步有可能将 3D 细胞培养的应用扩展到实验室建模的更复杂的器官系统。未来几年,预计与 3D 细胞培养相关的研究活动将会增加,其在治疗领域的应用也将增加。
区域洞察
在美洲,技术进步和大量研发投资正在扩大 3D 细胞培养在製药和生物技术产业的使用。许多当地企业正在致力于製造 3D 细胞培养系统。该地区全面的法律规范和对细胞研究的重视进一步推动了市场的发展。由于医疗保健支出不断增加、人口老化以及各种慢性疾病的流行,亚太地区成为 3D 细胞培养的新兴市场。中国、日本和韩国的生物技术领域正在显着成长,进一步促进了这些文化的应用和生产。欧洲也是一个重要的参与者,德国、英国和法国在细胞研究方面投入大量资金。 3D 细胞培养广泛应用于癌症研究、药物开发和再生医学。该地区的公司受到欧洲药品管理局 (EMA) 等机构全面监管的支持。与其他地区相比,中东和非洲地区虽然不是很发达,但正在稳步繁荣。整体医疗保健意识的提高、政府对医疗基础设施的支出以及全球製药公司的快速成长正在推动该地区的成长。
FPNV定位矩阵
FPNV定位矩阵对于评估3D细胞培养市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对 3D 细胞培养市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-3D细胞培养市场的市场规模与预测是多少?
2-在 3D 细胞培养市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3-3D细胞培养市场的技术趋势和法律规范是什么?
4-3D细胞培养市场主要厂商的市场占有率是多少?
5-进入3D细胞培养市场的合适型态和策略手段是什么?
[188 Pages Report] The 3D Cell Culture Market size was estimated at USD 1.62 billion in 2023 and expected to reach USD 1.73 billion in 2024, at a CAGR 7.34% to reach USD 2.67 billion by 2030.
Global 3D Cell Culture Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.62 billion |
Estimated Year [2024] | USD 1.73 billion |
Forecast Year [2030] | USD 2.67 billion |
CAGR (%) | 7.34% |
3D cell culture refers to the practice of growing biological cells in an environment where they can extend in all three dimensions. This method differs from traditional 2D methods that grow cells on flat surfaces, such as petri dishes. In a 3D cell culture, the cells mimic the behavior of cells within the human body much closer compared to 2D protocols, allowing for a more accurate interpretation of in vivo conditions. 3D cell cultures are instrumental in studying critical areas in biomedical research such as tissue regeneration, cancer biology, and drug discovery. The demand for organ transplantations has increased dramatically in recent years, pushing the need for 3D cultures that can create biomimetic tissue models for transplantations. However, complex infrastructure requirements for 3D cell culture development and their limited scalability impede their adoption. With the advancement in microfabrication and bio-printing technologies, the application of 3D cell culture can extend into more complex organ systems to be modeled in the laboratory. In the coming years, we are expected to observe a rise in research activities on 3D cell culture and their increasing applications in therapeutic areas.
Regional Insights
In the American continent, the use of 3D cell culture in the pharma-biotech industry is prevalent due to technological advancement and hefty R&D investments. Many local corporations are working on the production of 3D cell culture systems. The region's comprehensive regulatory frameworks and a strong emphasis on cell research propel the market further. Asia-Pacific is an emerging market for 3D cell culture due to increasing healthcare expenditure, a rise in the aging population, and the prevalence of diverse chronic diseases. China, Japan, and South Korea are witnessing significant growth in the biotechnology sector, which further fuels the application and production of these cultures. Europe is also a significant player, with Germany, UK, and France heavily investing in cell research. 3D cell cultures are extensively used for oncological research, drug development, and regenerative medicines. Companies in the region are supported by comprehensive regulations from agencies, including the European Medicines Agency (EMA). In comparison to other regions, the MEA has a less developed but steadily prospering 3D cell culture scene. Increasing general healthcare awareness, government expenditure on healthcare infrastructure, and the burgeoning presence of global pharmaceutical companies mark the growth in this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the 3D Cell Culture Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Cell Culture Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the 3D Cell Culture Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek, LLC, Altis Biosystems, Inc., Avantor, Inc., Becton, Dickinson and Company, BellBrook Labs, Cellink by Bico Group, CN Bio Innovations Limited, Copner Biotech, Corning Inc., Curesponse Ltd., Electrospinning Company Ltd., Emulate, Inc., Greiner Bio-One International GmbH, Hamilton Company, InSphero AG, JSR Corporation, Known Medicine, Lonza Group AG, Merck KGaA, MIMETAS, Ovizio Imaging Systems SA/NV, PromoCell GmbH, Reprocell Inc., SARSTEDT AG & Co. KG, Spiderwort Inc., Synthecon Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc, TissUse GmbH, and TreeFrog Therapeutics SAS.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the 3D Cell Culture Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Cell Culture Market?
3. What are the technology trends and regulatory frameworks in the 3D Cell Culture Market?
4. What is the market share of the leading vendors in the 3D Cell Culture Market?
5. Which modes and strategic moves are suitable for entering the 3D Cell Culture Market?